/home/u111169/mgh/grpo.py:8: FutureWarning: A value is trying to be set on a copy of a DataFrame or Series through chained assignment using an inplace method.
The behavior will change in pandas 3.0. This inplace method will never work because the intermediate object on which we are setting values always behaves as a copy.

For example, when doing 'df[col].method(value, inplace=True)', try using 'df.method({col: value}, inplace=True)' or df[col] = df[col].method(value) instead, to perform the operation inplace on the original object.


  df["labels"].replace({"<APPROVED>":"approved" , "<NOT APPROVED>":"unapproved"} , inplace=True)
ü¶• Unsloth: Will patch your computer to enable 2x faster free finetuning.
Unsloth: Failed to patch Gemma3ForConditionalGeneration.
ü¶• Unsloth Zoo will now patch everything to make training faster!
INFO 04-11 01:46:25 [__init__.py:239] Automatically detected platform cuda.
==((====))==  Unsloth 2025.3.19: Fast Llama patching. Transformers: 4.51.1. vLLM: 0.8.3.
   \\   /|    Tesla V100-PCIE-32GB. Num GPUs = 1. Max memory: 31.739 GB. Platform: Linux.
O^O/ \_/ \    Torch: 2.6.0+cu124. CUDA: 7.0. CUDA Toolkit: 12.4. Triton: 3.2.0
\        /    Bfloat16 = FALSE. FA [Xformers = 0.0.29.post3. FA2 = False]
 "-____-"     Free license: http://github.com/unslothai/unsloth
Unsloth: Fast downloading is enabled - ignore downloading bars which are red colored!
Unsloth: Your GPU does not support prefix caching - will disable!
Unsloth: vLLM loading /home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659 with actual GPU utilization = 59.35%
Unsloth: Your GPU has CUDA compute capability 7.0 with VRAM = 31.74 GB.
Unsloth: Using conservativeness = 1.0. Chunked prefill tokens = 5000. Num Sequences = 160.
Unsloth: vLLM's KV Cache can use up to 3.8 GB. Also swap space = 6 GB.
WARNING 04-11 01:46:28 [config.py:2704] Casting torch.bfloat16 to torch.float16.
INFO 04-11 01:46:36 [config.py:600] This model supports multiple tasks: {'generate', 'reward', 'score', 'embed', 'classify'}. Defaulting to 'generate'.
WARNING 04-11 01:46:36 [arg_utils.py:1708] Compute Capability < 8.0 is not supported by the V1 Engine. Falling back to V0. 
Unsloth: vLLM Bitsandbytes config using kwargs = {'load_in_8bit': False, 'load_in_4bit': True, 'bnb_4bit_compute_dtype': 'float16', 'bnb_4bit_quant_storage': 'uint8', 'bnb_4bit_quant_type': 'fp4', 'bnb_4bit_use_double_quant': False, 'llm_int8_enable_fp32_cpu_offload': False, 'llm_int8_has_fp16_weight': False, 'llm_int8_skip_modules': [], 'llm_int8_threshold': 6.0}
INFO 04-11 01:46:36 [llm_engine.py:242] Initializing a V0 LLM engine (v0.8.3) with config: model='/home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659', speculative_config=None, tokenizer='/home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659', skip_tokenizer_init=False, tokenizer_mode=auto, revision=None, override_neuron_config=None, tokenizer_revision=None, trust_remote_code=False, dtype=torch.float16, max_seq_len=5000, download_dir=None, load_format=LoadFormat.BITSANDBYTES, tensor_parallel_size=1, pipeline_parallel_size=1, disable_custom_all_reduce=False, quantization=bitsandbytes, enforce_eager=False, kv_cache_dtype=auto,  device_config=cuda:0, decoding_config=DecodingConfig(guided_decoding_backend='xgrammar', reasoning_backend=None), observability_config=ObservabilityConfig(show_hidden_metrics=False, otlp_traces_endpoint=None, collect_model_forward_time=False, collect_model_execute_time=False), seed=0, served_model_name=/home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659, num_scheduler_steps=1, multi_step_stream_outputs=True, enable_prefix_caching=False, chunked_prefill_enabled=False, use_async_output_proc=True, disable_mm_preprocessor_cache=False, mm_processor_kwargs=None, pooler_config=None, compilation_config={"level":0,"splitting_ops":[],"compile_sizes":[],"cudagraph_capture_sizes":[160,152,144,136,128,120,112,104,96,88,80,72,64,56,48,40,32,24,16,8,4,2,1],"max_capture_size":160}, use_cached_outputs=False, 
/share/apps/eb/Python/3.11.5-GCCcore-13.2.0/envs/vllm/lib/python3.11/site-packages/vllm/executor/uniproc_executor.py:29: UserWarning: Failed to get the IP address, using 0.0.0.0 by default.The value can be set by the environment variable VLLM_HOST_IP or HOST_IP.
  get_ip(), get_open_port())
INFO 04-11 01:46:37 [cuda.py:240] Cannot use FlashAttention-2 backend for Volta and Turing GPUs.
INFO 04-11 01:46:37 [cuda.py:289] Using XFormers backend.
[W411 01:46:37.492937029 socket.cpp:204] [c10d] The hostname of the client socket cannot be retrieved. err=-3
[W411 01:46:37.493136480 socket.cpp:204] [c10d] The hostname of the client socket cannot be retrieved. err=-3
INFO 04-11 01:46:37 [parallel_state.py:957] rank 0 in world size 1 is assigned as DP rank 0, PP rank 0, TP rank 0
INFO 04-11 01:46:37 [model_runner.py:1110] Starting to load model /home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659...
INFO 04-11 01:46:38 [loader.py:1155] Loading weights with BitsAndBytes quantization. May take a while ...
Loading safetensors checkpoint shards:   0% Completed | 0/4 [00:00<?, ?it/s]
Loading safetensors checkpoint shards:  25% Completed | 1/4 [00:20<01:01, 20.66s/it]
Loading safetensors checkpoint shards:  50% Completed | 2/4 [01:53<02:06, 63.21s/it]
Loading safetensors checkpoint shards:  75% Completed | 3/4 [03:10<01:09, 69.32s/it]
Loading safetensors checkpoint shards: 100% Completed | 4/4 [04:38<00:00, 76.80s/it]
Loading safetensors checkpoint shards: 100% Completed | 4/4 [04:38<00:00, 69.63s/it]

INFO 04-11 01:51:16 [punica_selector.py:18] Using PunicaWrapperGPU.
INFO 04-11 01:51:17 [model_runner.py:1146] Model loading took 5.4442 GiB and 278.775735 seconds
INFO 04-11 01:51:26 [worker.py:267] Memory profiling takes 9.01 seconds
INFO 04-11 01:51:26 [worker.py:267] the current vLLM instance can use total_gpu_memory (31.74GiB) x gpu_memory_utilization (0.59) = 18.84GiB
INFO 04-11 01:51:26 [worker.py:267] model weights take 5.44GiB; non_torch_memory takes 0.07GiB; PyTorch activation peak memory takes 0.77GiB; the rest of the memory reserved for KV Cache is 12.55GiB.
INFO 04-11 01:51:26 [executor_base.py:112] # cuda blocks: 6426, # CPU blocks: 3072
INFO 04-11 01:51:26 [executor_base.py:117] Maximum concurrency for 5000 tokens per request: 20.56x
INFO 04-11 01:51:29 [model_runner.py:1456] Capturing cudagraphs for decoding. This may lead to unexpected consequences if the model is not static. To run the model in eager mode, set 'enforce_eager=True' or use '--enforce-eager' in the CLI. If out-of-memory error occurs during cudagraph capture, consider decreasing `gpu_memory_utilization` or switching to eager mode. You can also reduce the `max_num_seqs` as needed to decrease memory usage.
Capturing CUDA graph shapes:   0%|          | 0/23 [00:00<?, ?it/s]Capturing CUDA graph shapes:   4%|‚ñç         | 1/23 [00:01<00:42,  1.95s/it]Capturing CUDA graph shapes:   9%|‚ñä         | 2/23 [00:03<00:37,  1.81s/it]Capturing CUDA graph shapes:  13%|‚ñà‚ñé        | 3/23 [00:05<00:35,  1.76s/it]Capturing CUDA graph shapes:  17%|‚ñà‚ñã        | 4/23 [00:07<00:32,  1.73s/it]Capturing CUDA graph shapes:  22%|‚ñà‚ñà‚ñè       | 5/23 [00:08<00:28,  1.60s/it]Capturing CUDA graph shapes:  26%|‚ñà‚ñà‚ñå       | 6/23 [00:09<00:25,  1.52s/it]Capturing CUDA graph shapes:  30%|‚ñà‚ñà‚ñà       | 7/23 [00:11<00:23,  1.46s/it]Capturing CUDA graph shapes:  35%|‚ñà‚ñà‚ñà‚ñç      | 8/23 [00:12<00:21,  1.41s/it]Capturing CUDA graph shapes:  39%|‚ñà‚ñà‚ñà‚ñâ      | 9/23 [00:13<00:19,  1.39s/it]Capturing CUDA graph shapes:  43%|‚ñà‚ñà‚ñà‚ñà‚ñé     | 10/23 [00:15<00:17,  1.36s/it]Capturing CUDA graph shapes:  48%|‚ñà‚ñà‚ñà‚ñà‚ñä     | 11/23 [00:16<00:16,  1.35s/it]Capturing CUDA graph shapes:  52%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñè    | 12/23 [00:17<00:14,  1.34s/it]Capturing CUDA graph shapes:  57%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñã    | 13/23 [00:18<00:12,  1.28s/it]Capturing CUDA graph shapes:  61%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà    | 14/23 [00:20<00:11,  1.24s/it]Capturing CUDA graph shapes:  65%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñå   | 15/23 [00:21<00:09,  1.22s/it]Capturing CUDA graph shapes:  70%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñâ   | 16/23 [00:22<00:08,  1.20s/it]Capturing CUDA graph shapes:  74%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñç  | 17/23 [00:23<00:07,  1.18s/it]Capturing CUDA graph shapes:  78%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñä  | 18/23 [00:24<00:05,  1.17s/it]Capturing CUDA graph shapes:  83%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñé | 19/23 [00:25<00:04,  1.17s/it]Capturing CUDA graph shapes:  87%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñã | 20/23 [00:26<00:03,  1.15s/it]Capturing CUDA graph shapes:  91%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñè| 21/23 [00:28<00:02,  1.15s/it]Capturing CUDA graph shapes:  96%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñå| 22/23 [00:29<00:01,  1.15s/it]Capturing CUDA graph shapes: 100%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà| 23/23 [00:29<00:00,  1.03s/it]Capturing CUDA graph shapes: 100%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà| 23/23 [00:29<00:00,  1.30s/it]
INFO 04-11 01:51:59 [model_runner.py:1598] Graph capturing finished in 30 secs, took 3.07 GiB
INFO 04-11 01:51:59 [llm_engine.py:448] init engine (profile, create kv cache, warmup model) took 42.31 seconds
/home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659 does not have a padding token! Will use pad_token = <|finetune_right_pad_id|>.
Unsloth 2025.3.19 patched 32 layers with 32 QKV layers, 32 O layers and 32 MLP layers.
Map:   0%|          | 0/2497 [00:00<?, ? examples/s]Map:  64%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñç   | 1610/2497 [00:00<00:00, 16012.67 examples/s]Map: 100%|‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà‚ñà| 2497/2497 [00:00<00:00, 14655.86 examples/s]
Unsloth: We now expect `per_device_train_batch_size` to be a multiple of `num_generations`.
We will change the batch size of 1 to the `num_generations` of 4
WARNING:accelerate.utils.other:Detected kernel version 5.3.18, which is below the recommended minimum of 5.5.0; this can cause the process to hang. It is recommended to upgrade the kernel to the minimum version or higher.
==((====))==  Unsloth - 2x faster free finetuning | Num GPUs used = 1
   \\   /|    Num examples = 2,497 | Num Epochs = 1 | Total steps = 250
O^O/ \_/ \    Batch size per device = 4 | Gradient accumulation steps = 1
\        /    Data Parallel GPUs = 1 | Total batch size (4 x 1 x 1) = 4
 "-____-"     Trainable parameters = 41,943,040/8,000,000,000 (0.52% trained)
  0%|          | 0/250 [00:00<?, ?it/s]-------------------- Question:

            I have developed a model that can predict the drug likelibility of compound X.
            This model outputs two lists:
            1. The five most similar approved small molecules (with their properties and similarity scores).
            2. The five most similar non-approved small molecules (with their properties and similarity scores).

            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 263.38, 'LogP': 2.63, 'Molecular Refractivity': 77.4, 'TPSA': 32.7, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 2, 'Heavy Atoms': 19, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.99, 'Rdkit information': {'Molecular Weight': 263.38, 'LogP': 2.63, 'Molecular Refractivity': 77.4, 'TPSA': 32.70, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 19, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.98, 'Rdkit information': {'Molecular Weight': 299.84, 'LogP': 3.06, 'Molecular Refractivity': 84.65, 'TPSA': 32.70, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 20, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.95, 'Rdkit information': {'Molecular Weight': 237.73, 'LogP': 2.9, 'Molecular Refractivity': 65.66, 'TPSA': 29.10, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 2, 'Chiral Centers': 0, 'Heavy Atoms': 16, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.94, 'Rdkit information': {'Molecular Weight': 309.41, 'LogP': 3.42, 'Molecular Refractivity': 93.94, 'TPSA': 30.29, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 23, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['Aliphatic_long_chain']}}, 5: { 'similarity score': 0.94, 'Rdkit information': {'Molecular Weight': 264.37, 'LogP': 2.62, 'Molecular Refractivity': 78.68, 'TPSA': 41.57, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 8, 'Chiral Centers': 0, 'Heavy Atoms': 19, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['Aliphatic_long_chain']}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 281.42, 'LogP': 2.68, 'Molecular Refractivity': 78.26, 'TPSA': 37.38, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 19, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 315.84, 'LogP': 4.38, 'Molecular Refractivity': 94.71, 'TPSA': 12.47, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 3, 'Chiral Centers': 0, 'Heavy Atoms': 22, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 341.45, 'LogP': 3.24, 'Molecular Refractivity': 100.2, 'TPSA': 58.56, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 11, 'Chiral Centers': 1, 'Heavy Atoms': 25, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': ['Aliphatic_long_chain']}}, 4: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 295.85, 'LogP': 4.17, 'Molecular Refractivity': 85.5, 'TPSA': 12.47, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 8, 'Chiral Centers': 0, 'Heavy Atoms': 20, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': ['Aliphatic_long_chain']}}, 5: { 'similarity score': 0.91, 'Rdkit information': {'Molecular Weight': 313.87, 'LogP': 4.59, 'Molecular Refractivity': 97.79, 'TPSA': 3.24, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 1, 'Rotatable Bonds': 3, 'Chiral Centers': 0, 'Heavy Atoms': 22, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['styrene_A(13)']}}}}
             
Answer:
approved 
Response:
<think>
To determine the likelihood of compound X receiving regulatory approval based on its similarity to known molecules, we need to analyze the provided data.

Compound X has a molecular weight of 263.38, logP of 2.63, molecular refractivity of 77.4, TPSA of 32.7, 1 hydrogen bond donor, 3 hydrogen bond acceptors, 4 rotatable bonds, 2 chiral centers, 19 heavy atoms, a formal charge of 0, and 2 total rings with no structural alerts.

The most similar approved drugs to Compound X are:

- Drug 1 with a similarity score of 0.99, having a molecular weight of 263.38, logP of 2.63, molecular refractivity of 77.4, TPSA of 32.7, 1 hydrogen bond donor, 3 hydrogen bond acceptors, 4 rotatable bonds, 0 chiral centers, 19 heavy atoms, a formal charge of 0, and 2 total rings with no structural alerts.
- Drug 2 with a similarity score of 0.98, having a molecular weight of 299.84, logP of 3.06, molecular refractivity of 84.65, TPSA of 32.7, 1 hydrogen bond donor, 3 hydrogen bond acceptors, 4 rotatable bonds, 0 chiral centers, 20 heavy atoms, a formal charge of 0, and 2 total rings with no structural alerts.
- Drug 3 with a similarity score of 0.95, having a molecular weight of 237.73, logP of 2.9, molecular refractivity of 65.66, TPSA of 29.1, 1 hydrogen bond donor, 2 hydrogen bond acceptors, 2 rotatable bonds, 0 chiral centers, 16 heavy atoms, a formal charge of 0, and 2 total rings with no structural alerts.
- Drug 4 with a similarity score of 0.94, having a molecular weight of 309.41, logP of 3.42, molecular refractivity of 93.94, TPSA of 30.29, 0 hydrogen bond donors, 4 hydrogen bond acceptors, 7 rotatable bonds, 0 chiral centers, 23 heavy atoms, a formal charge of 0, and 3 total rings with aliphatic_long_chain structural alerts.
- Drug 5 with a similarity score of 0.94, having a molecular weight of 264.37, logP of 2.62, molecular refractivity of 78.68, TPSA of 41.57, 1 hydrogen bond donor, 4 hydrogen bond acceptors, 8 rotatable bonds, 0 chiral centers, 19 heavy atoms, a formal charge of 0, and 1 total ring with aliphatic_long_chain structural alerts.

The most similar non-approved drugs to Compound X are:

- Drug 1 with a similarity score of 0.92, having a molecular weight of 281.42, logP of 2.68, molecular refractivity of 78.26, TPSA of 37.38, 0 hydrogen bond donors, 3 hydrogen bond acceptors, 4 rotatable bonds, 0 chiral centers, 19 heavy atoms, a formal charge of 0, and 2 total rings with no structural alerts.
- Drug 2 with a similarity score of 0.92, having a molecular weight of 315.84, logP of 4.38, molecular refractivity of 94.71, TPSA of 12.47, 0 hydrogen bond donors, 2 hydrogen bond acceptors, 3 rotatable bonds, 0 chiral centers, 22 heavy atoms, a formal charge of 0, and 3 total rings with no structural alerts.
- Drug 3 with a similarity score of 0.92, having a molecular weight of 341.45, logP of 3.24, molecular refractivity of 100.2, TPSA of 58.56, 2 hydrogen bond donors, 4 hydrogen bond acceptors, 11 rotatable bonds, 1 chiral center, 25 heavy atoms, a formal charge of 0, and 2 total rings with aliphatic_long_chain structural alerts.
- Drug 4 with a similarity score of 0.92, having a molecular weight of 295.85, logP of 4.17, molecular refractivity of 85.5, TPSA of 12.47, 0 hydrogen bond donors, 2 hydrogen bond acceptors, 8 rotatable bonds, 0 chiral centers, 20 heavy atoms, a formal charge of 0, and 2 total rings with aliphatic_long_chain structural alerts.
- Drug 5 with a similarity score of 0.91, having a molecular weight of 313.87, logP of 4.59, molecular refractivity of 97.79, TPSA of 3.24, 0 hydrogen bond donors, 1 hydrogen bond acceptor, 3 rotatable bonds, 0 chiral centers, 22 heavy atoms, a formal charge of 0, and 3 total rings with styrene_A(13) structural alerts.

Given that most of the similar approved drugs have similar structural features to Compound X, but also some structural alerts in the most similar non-approved drugs, this makes the case slightly challenging to decide.

However, the high similarity scores of 0.99 and 0.98 with approved drugs, and the similar structural alerts with common non-approved drugs, suggests that drug likeliness is present.

</think>
<label>
Approved
</label>
<score>
6/10
</score>
Note: Based on this analysis, the decision is based on the similarity scores of the most similar approved and non-approved drugs. However, the structural alerts in the non-approved drugs cast some doubt on the compound's drug likeliness. Therefore, the decision is not completely confident. 
Extracted:
Approved
  0%|          | 1/250 [03:28<14:25:26, 208.54s/it]                                                   {'loss': -0.0, 'grad_norm': 0.17708177864551544, 'learning_rate': 0.0, 'rewards/xmlcount_reward_func': -1.3927500247955322, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.0, 'rewards/correctness_reward_func': 0.0, 'rewards/int_score_reward_func': 0.0, 'reward': -1.3927500247955322, 'reward_std': 0.7131953835487366, 'completion_length': 648.5, 'kl': 0.0, 'epoch': 0.0}
  0%|          | 1/250 [03:28<14:25:26, 208.54s/it]-------------------- Question:

            I have developed a model that can predict the drug likelibility of compound X.
            This model outputs two lists:
            1. The five most similar approved small molecules (with their properties and similarity scores).
            2. The five most similar non-approved small molecules (with their properties and similarity scores).

            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 1486.57, 'LogP': -7.85, 'Molecular Refractivity': 364.21, 'TPSA': 488.88, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 100, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.88, 'Rdkit information': {'Molecular Weight': 1500.55, 'LogP': -7.76, 'Molecular Refractivity': 364.76, 'TPSA': 505.95, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 101, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}, 2: { 'similarity score': 0.78, 'Rdkit information': {'Molecular Weight': 1394.59, 'LogP': -3.4, 'Molecular Refractivity': 355.87, 'TPSA': 494.22, 'Hydrogen Bond_Donors': 17, 'Hydrogen_Bond Acceptors': 21, 'Rotatable Bonds': 34, 'Chiral Centers': 10, 'Heavy Atoms': 97, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}, 3: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 511.51, 'LogP': -3.37, 'Molecular Refractivity': 120.12, 'TPSA': 225.76, 'Hydrogen Bond_Donors': 5, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 10, 'Chiral Centers': 1, 'Heavy Atoms': 35, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}, 4: { 'similarity score': 0.73, 'Rdkit information': {'Molecular Weight': 473.45, 'LogP': -0.73, 'Molecular Refractivity': 120.78, 'TPSA': 219.84, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 10, 'Chiral Centers': 1, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}, 5: { 'similarity score': 0.72, 'Rdkit information': {'Molecular Weight': 681.75, 'LogP': -4.68, 'Molecular Refractivity': 119.85, 'TPSA': 213.94, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 20, 'Chiral Centers': 1, 'Heavy Atoms': 38, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.89, 'Rdkit information': {'Molecular Weight': 1609.57, 'LogP': -7.38, 'Molecular Refractivity': 359.0, 'TPSA': 505.95, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 101, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}, 2: { 'similarity score': 0.75, 'Rdkit information': {'Molecular Weight': 573.67, 'LogP': -0.46, 'Molecular Refractivity': 150.45, 'TPSA': 199.95, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 16, 'Chiral Centers': 3, 'Heavy Atoms': 40, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.73, 'Rdkit information': {'Molecular Weight': 473.45, 'LogP': -0.73, 'Molecular Refractivity': 120.78, 'TPSA': 219.84, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 10, 'Chiral Centers': 2, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}, 4: { 'similarity score': 0.71, 'Rdkit information': {'Molecular Weight': 752.23, 'LogP': -0.18, 'Molecular Refractivity': 179.0, 'TPSA': 256.90, 'Hydrogen Bond_Donors': 6, 'Hydrogen_Bond Acceptors': 14, 'Rotatable Bonds': 13, 'Chiral Centers': 2, 'Heavy Atoms': 50, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['catechol_A(92)', 'catechol', 'imine_1', 'Oxygen-nitrogen_single_bond', 'quaternary_nitrogen_2']}}, 5: { 'similarity score': 0.71, 'Rdkit information': {'Molecular Weight': 588.67, 'LogP': -1.97, 'Molecular Refractivity': 151.75, 'TPSA': 235.91, 'Hydrogen Bond_Donors': 8, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 9, 'Chiral Centers': 4, 'Heavy Atoms': 42, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': ['Aliphatic_long_chain', 'imine_1', 'imine_2']}}}}
             
Answer:
unapproved 
Response:
<think>
To analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules, I'll start by looking at the most similar approved small molecules. The highest similarity score among these is 0.88, indicating a high degree of similarity. However, the approved molecules are quite large in size (molecular weights ranging from 1394.59 to 1500.55), which might raise concerns about their solubility and bioavailability.

Next, I'll examine the most similar non-approved small molecules. The highest similarity score among these is 0.89, which is slightly higher than the highest score among the approved molecules. However, these non-approved molecules are also large in size, with molecular weights ranging from 1609.57 to 573.67.

Considering the similarities and differences between the approved and non-approved molecules, I notice that the structural alerts are similar for both sets of compounds. The most common structural alerts are 'Aliphatic_long_chain', 'disulphide', and 'aldehyde'. These alerts suggest the presence of lipophilic regions, which could contribute to the compounds' cell membrane permeability. However, they also indicate potential toxicological concerns, such as oxidative stress and aldehyde-mediated damage.

Although the similarity scores are high, the large size of the compounds and the presence of toxicological alerts raise concerns about their potential as lead compounds. Furthermore, the absence of smaller molecules with high similarity scores in the approved drugs list might indicate a potential lack of potency or selectivity.

Considering all these factors, I would argue that compound X has a moderate to low likelihood of receiving regulatory approval.
</think>
<label>
unapproved
</label>
<score>
6/10
</score> 
Extracted:
unapproved
Unsloth: Will smartly offload gradients to save VRAM!
  1%|          | 2/250 [05:58<12:00:33, 174.33s/it]                                                   {'loss': 0.0, 'grad_norm': 0.2358548641204834, 'learning_rate': 2.0000000000000002e-07, 'rewards/xmlcount_reward_func': -1.7257499694824219, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.25, 'rewards/correctness_reward_func': 1.5, 'rewards/int_score_reward_func': 0.0, 'reward': 0.02424997091293335, 'reward_std': 3.1636993885040283, 'completion_length': 415.0, 'kl': 0.0, 'epoch': 0.0}
  1%|          | 2/250 [05:58<12:00:33, 174.33s/it]-------------------- Question:

            I have developed a model that can predict the drug likelibility of compound X.
            This model outputs two lists:
            1. The five most similar approved small molecules (with their properties and similarity scores).
            2. The five most similar non-approved small molecules (with their properties and similarity scores).

            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 448.45, 'LogP': 3.66, 'Molecular Refractivity': 111.28, 'TPSA': 97.12, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 5, 'Chiral Centers': 1, 'Heavy Atoms': 32, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.8, 'Rdkit information': {'Molecular Weight': 522.58, 'LogP': 2.01, 'Molecular Refractivity': 127.75, 'TPSA': 138.44, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 11, 'Rotatable Bonds': 10, 'Chiral Centers': 6, 'Heavy Atoms': 36, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.79, 'Rdkit information': {'Molecular Weight': 506.61, 'LogP': 4.94, 'Molecular Refractivity': 140.71, 'TPSA': 75.00, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 37, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.79, 'Rdkit information': {'Molecular Weight': 447.54, 'LogP': 2.97, 'Molecular Refractivity': 128.65, 'TPSA': 105.04, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 5, 'Chiral Centers': 0, 'Heavy Atoms': 33, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 489.93, 'LogP': 5.54, 'Molecular Refractivity': 124.03, 'TPSA': 91.92, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 33, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': 'None'}}, 5: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 375.4, 'LogP': 1.98, 'Molecular Refractivity': 99.63, 'TPSA': 83.80, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 6, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 27, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': 'None'}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.79, 'Rdkit information': {'Molecular Weight': 415.43, 'LogP': 3.75, 'Molecular Refractivity': 115.64, 'TPSA': 101.38, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 5, 'Chiral Centers': 1, 'Heavy Atoms': 31, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.78, 'Rdkit information': {'Molecular Weight': 560.65, 'LogP': 5.03, 'Molecular Refractivity': 156.83, 'TPSA': 85.52, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 6, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 41, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 573.68, 'LogP': 1.83, 'Molecular Refractivity': 152.15, 'TPSA': 179.64, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 40, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['Sulfonic_acid_2']}}, 4: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 461.51, 'LogP': 3.61, 'Molecular Refractivity': 124.64, 'TPSA': 116.13, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 6, 'Chiral Centers': 1, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['2-halo_pyridine']}}, 5: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 396.5, 'LogP': 2.28, 'Molecular Refractivity': 111.78, 'TPSA': 92.63, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 7, 'Chiral Centers': 1, 'Heavy Atoms': 29, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': ['N_oxide', 'quaternary_nitrogen_1']}}}}
             
Answer:
unapproved 
Response:
<think>
To assess the likelihood of compound X receiving regulatory approval, let's first examine its similarity to known molecules.

The compound's size and shape can be gauged by its molecular weight and TPSA (Topological Polar Surface Area). The larger the molecular weight and TPSA, generally, the more difficult it is for the compound to pass through cell membranes and undergo metabolic processes, increasing the chances of regulatory approval. The LogP (octanol-water partition coefficient) also affects permeability and lipophilicity. With a LogP of 3.66, compound X is relatively non-polar and may have better permeability.

Compound X has a relatively low molecular weight (448.45) and moderate TPSA (97.12), indicating it may be relatively less lipophilic and have moderate permeability relative to the most similar approved and non-approved drugs. Compounds with high TPSA tend to be more polar and hydrophilic, suggesting a lower likelihood of crossing cell membranes, but it may also require more energy during metabolic processes.

Out of the five most similar approved drugs, compound X is most similar to drug 1 with a similarity score of 0.8, which has a higher molecular weight (522.58) and similar LogP (2.01) and TPSA (138.44). Although Compound X and drug 1 share a lot of similarities, structural alerts are also absent in drug 1, suggesting it's a positive signal towards regulatory approval. Thus, the presence of structural alerts in Compound X is a negative signal. However, this doesn't necessarily disqualify Compound X as a drug candidate, but it may require further investigation.

Looking at the five most similar non-approved drugs, compound X is most similar to drug 2 with a similarity score of 0.79, which has a larger molecular weight (560.65) and a higher TPSA (85.52). The significant difference in size and TPSA between Compound X and drug 2, particularly considering the high TPSA of the latter, suggests that Compound X may face challenges in crossing cell membranes and undergoing metabolic processes. A higher molecular weight typically requires more metabolic energy and/or myriad protein interactions to break down, a common regulatory hurdle during new drug development.

Given these factors, the likelihood of regulatory approval relies on various parameters.

</think>
<label>
**Approved</label>
<score>
7/10
</score>

My reasoning led to this conclusion based on the high similarity score with the approved drugs despite negative structural alerts in Compound X. 
Extracted:
**Approved
  1%|          | 3/250 [08:44<11:41:37, 170.44s/it]                                                   {'loss': 0.0, 'grad_norm': 0.24322469532489777, 'learning_rate': 4.0000000000000003e-07, 'rewards/xmlcount_reward_func': -0.7047500014305115, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.125, 'rewards/correctness_reward_func': 0.75, 'rewards/int_score_reward_func': 0.0, 'reward': 0.17024999856948853, 'reward_std': 2.0695302486419678, 'completion_length': 470.25, 'kl': 1.089875240722904e-05, 'epoch': 0.0}
  1%|          | 3/250 [08:44<11:41:37, 170.44s/it]-------------------- Question:

            I have developed a model that can predict the drug likelibility of compound X.
            This model outputs two lists:
            1. The five most similar approved small molecules (with their properties and similarity scores).
            2. The five most similar non-approved small molecules (with their properties and similarity scores).

            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 197.19, 'LogP': 0.05, 'Molecular Refractivity': 49.09, 'TPSA': 103.78, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 14, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.99, 'Rdkit information': {'Molecular Weight': 211.22, 'LogP': 0.44, 'Molecular Refractivity': 53.7, 'TPSA': 103.78, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 15, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}}, 2: { 'similarity score': 0.98, 'Rdkit information': {'Molecular Weight': 213.19, 'LogP': -0.46, 'Molecular Refractivity': 50.34, 'TPSA': 124.01, 'Hydrogen Bond_Donors': 5, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 3, 'Chiral Centers': 2, 'Heavy Atoms': 15, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}}, 3: { 'similarity score': 0.95, 'Rdkit information': {'Molecular Weight': 169.18, 'LogP': 0.09, 'Molecular Refractivity': 43.79, 'TPSA': 86.71, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 2, 'Chiral Centers': 1, 'Heavy Atoms': 12, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}}, 4: { 'similarity score': 0.95, 'Rdkit information': {'Molecular Weight': 153.18, 'LogP': 0.6, 'Molecular Refractivity': 42.53, 'TPSA': 66.48, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 2, 'Chiral Centers': 0, 'Heavy Atoms': 11, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}}, 5: { 'similarity score': 0.94, 'Rdkit information': {'Molecular Weight': 226.23, 'LogP': -0.05, 'Molecular Refractivity': 56.84, 'TPSA': 115.81, 'Hydrogen Bond_Donors': 5, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 4, 'Chiral Centers': 1, 'Heavy Atoms': 16, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol', 'hydrazine', 'Oxygen-nitrogen_single_bond']}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.96, 'Rdkit information': {'Molecular Weight': 181.19, 'LogP': 0.35, 'Molecular Refractivity': 47.42, 'TPSA': 83.55, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 13, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.96, 'Rdkit information': {'Molecular Weight': 195.22, 'LogP': 0.74, 'Molecular Refractivity': 52.04, 'TPSA': 83.55, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 14, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.94, 'Rdkit information': {'Molecular Weight': 218.26, 'LogP': 1.13, 'Molecular Refractivity': 62.23, 'TPSA': 68.25, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 16, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 373.45, 'LogP': 2.73, 'Molecular Refractivity': 103.28, 'TPSA': 99.02, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 9, 'Chiral Centers': 2, 'Heavy Atoms': 27, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 5: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 189.64, 'LogP': 1.02, 'Molecular Refractivity': 49.78, 'TPSA': 66.48, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 2, 'Chiral Centers': 0, 'Heavy Atoms': 12, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}}}}
             
Answer:
approved 
Response:
<think>

To begin with, I'll compare the provided compound X's properties with the most similar approved drugs to determine how closely they align with known successful drug candidates. The comparison will be based on the similarity scores and properties (Molecular Weight, LogP, Molecular Refractivity, TPSA, Hydrogen Bond Donors and Acceptors, Rotatable Bonds, Chiral Centers, Heavy Atoms, Formal Charge, and Total Rings) of the compound.

Compound X: 
{'Molecular Weight': 197.19, 'LogP': 0.05, 'Molecular Refractivity': 49.09, 'TPSA': 103.78, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 14, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}

Most similar approved drug: 
{1: {'similarity score': 0.99, 'Rdkit information': {'Molecular Weight': 211.22, 'LogP': 0.44, 'Molecular Refractivity': 53.7, 'TPSA': 103.78, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 15, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}}

The most similar approved drug (similarity score = 0.99) has a very high similarity score, but its molecular weight, LogP, and molecular refractivity are relatively higher than those of compound X. While its similarity score indicates a strong match, the differences in these properties might affect its overall viability.

Other approved drugs have lower similarity scores, with some key differences in their properties. For instance, the second most similar approved drug has more hydrogen bond donors and acceptors, and the third most similar approved drug is slightly smaller in size and has a different chemical structure.

Moving on, I'll compare compound X's properties with the most similar non-approved drugs. These comparisons will help identify potential issues or red flags that could impact regulatory approval.

The most similar non-approved drugs have high similarity scores (0.96 and 0.94) but differ in their molecular weights, LogP values, and structural alerts. Their properties show some inconsistencies, which could be indicative of potential issues in terms of pharmacokinetics, pharmacodynamics, or toxicity.

Considering these comparisons, the approved and non-approved drugs have varying degrees of similarity to compound X. While the approved drugs demonstrate some close matches in terms of similarity scores, differences in their properties should be considered. Similarly, the non-approved drugs have some similarities but raise potential concerns.

Based on these comparisons, my evaluation of compound X's potential as a regulatory-approved drug is less confident, mainly due to the presence of structural alerts and differences in properties from known approved drugs.

</think>

<label>

Unapproved

</label>

<score>

5

</score>

The model described suggests that compound X has some limitations based on its properties and comparisons with known approved and non-approved drugs. Its structural alerts and differences in molecular weight, LogP, and other properties from known approved drugs raise confidence concerns about its viability. 
Extracted:
Unapproved
  2%|‚ñè         | 4/250 [11:53<12:08:35, 177.70s/it]                                                   {'loss': 0.0, 'grad_norm': 0.2880227267742157, 'learning_rate': 6.000000000000001e-07, 'rewards/xmlcount_reward_func': -1.1040000915527344, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.125, 'rewards/correctness_reward_func': 0.75, 'rewards/int_score_reward_func': 0.0, 'reward': -0.2290000319480896, 'reward_std': 1.978534460067749, 'completion_length': 535.75, 'kl': 1.1606316547840834e-05, 'epoch': 0.0}
  2%|‚ñè         | 4/250 [11:53<12:08:35, 177.70s/it]-------------------- Question:

            I have developed a model that can predict the drug likelibility of compound X.
            This model outputs two lists:
            1. The five most similar approved small molecules (with their properties and similarity scores).
            2. The five most similar non-approved small molecules (with their properties and similarity scores).

            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 615.78, 'LogP': 6.16, 'Molecular Refractivity': 172.64, 'TPSA': 94.72, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 7, 'Chiral Centers': 3, 'Heavy Atoms': 43, 'Formal Charge': 0, 'Total Rings': 8, 'Structural Alerts': 'None'}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.81, 'Rdkit information': {'Molecular Weight': 421.47, 'LogP': 4.52, 'Molecular Refractivity': 117.03, 'TPSA': 90.65, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 8, 'Chiral Centers': 2, 'Heavy Atoms': 31, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.8, 'Rdkit information': {'Molecular Weight': 411.47, 'LogP': 4.63, 'Molecular Refractivity': 115.63, 'TPSA': 82.69, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 8, 'Chiral Centers': 2, 'Heavy Atoms': 30, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.8, 'Rdkit information': {'Molecular Weight': 586.2, 'LogP': 8.95, 'Molecular Refractivity': 171.25, 'TPSA': 70.42, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 12, 'Chiral Centers': 1, 'Heavy Atoms': 41, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.8, 'Rdkit information': {'Molecular Weight': 383.46, 'LogP': 0.65, 'Molecular Refractivity': 102.49, 'TPSA': 115.42, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 6, 'Chiral Centers': 1, 'Heavy Atoms': 28, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': 'None'}}, 5: { 'similarity score': 0.8, 'Rdkit information': {'Molecular Weight': 447.89, 'LogP': 4.28, 'Molecular Refractivity': 116.9, 'TPSA': 88.76, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 7, 'Chiral Centers': 1, 'Heavy Atoms': 31, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': 'None'}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 615.78, 'LogP': 6.98, 'Molecular Refractivity': 172.27, 'TPSA': 83.72, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 8, 'Chiral Centers': 3, 'Heavy Atoms': 43, 'Formal Charge': 0, 'Total Rings': 8, 'Structural Alerts': ['Oxygen-nitrogen_single_bond', 'peroxide']}}, 2: { 'similarity score': 0.88, 'Rdkit information': {'Molecular Weight': 482.54, 'LogP': 3.84, 'Molecular Refractivity': 136.9, 'TPSA': 89.68, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 2, 'Chiral Centers': 5, 'Heavy Atoms': 36, 'Formal Charge': 0, 'Total Rings': 8, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.84, 'Rdkit information': {'Molecular Weight': 570.65, 'LogP': 5.91, 'Molecular Refractivity': 165.12, 'TPSA': 77.73, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 6, 'Rotatable Bonds': 3, 'Chiral Centers': 4, 'Heavy Atoms': 43, 'Formal Charge': 0, 'Total Rings': 9, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.83, 'Rdkit information': {'Molecular Weight': 399.49, 'LogP': 4.32, 'Molecular Refractivity': 118.8, 'TPSA': 68.01, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 3, 'Chiral Centers': 2, 'Heavy Atoms': 30, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['Polycyclic_aromatic_hydrocarbon_3']}}, 5: { 'similarity score': 0.82, 'Rdkit information': {'Molecular Weight': 669.56, 'LogP': 4.3, 'Molecular Refractivity': 175.79, 'TPSA': 140.49, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 8, 'Chiral Centers': 5, 'Heavy Atoms': 46, 'Formal Charge': 0, 'Total Rings': 7, 'Structural Alerts': ['phthalimide']}}}}
             
Answer:
unapproved 
Response:
<think>
To assess the likelihood of compound X receiving regulatory approval, I'll analyze its similarity to known molecules. The provided data includes the similarity scores and RDKIT information for the top 5 most similar approved drugs and non-approved drugs.

First, I'll inspect the approved drugs:

The approved drugs have similarity scores ranging from 0.8 to 0.81, indicating moderate similarity. Upon examining the properties, I notice that they generally have lower molecular weights, logP values, and refractivity compared to compound X. The approved drugs also have fewer hydrogen bond donors and hydrogen bond acceptors.

Now, I'll examine the non-approved drugs:

The non-approved drugs have higher similarity scores, ranging from 0.82 to 0.92. Many of these compounds have similar molecular weights, logP values, and refractivity as compound X. However, some notable differences exist: non-approved compounds often have different structural alerts, which could be a concern. Compound X has a structural alert for 'Oxygen-nitrogen_single_bond', while some non-approved drugs have different structural alerts.

Upon analyzing the data, I notice that compound X is more similar to non-approved drugs than approved drugs. However, the non-approved drugs seem to have potential issues (e.g., different structural alerts). Considering this, I'm inclined to believe that compound X is less likely to be approved due to these structural concerns.

However, I must emphasize that this is a complex decision, and there are multiple factors to consider. The regulatory process would involve further analysis, experimental validation, and potentially additional studies.

</think>
<label>
Unapproved
</label>
<score>
6
</score>

Reasoning: While compound X is similar to approved drugs in some aspects, it's more similar to non-approved drugs and has potential structural issues, which makes its approval less likely. My confidence in this decision is moderate (score: 6). 
Extracted:
Unapproved
  2%|‚ñè         | 5/250 [14:24<11:26:08, 168.04s/it]                                                   {'loss': 0.0, 'grad_norm': 0.23844492435455322, 'learning_rate': 8.000000000000001e-07, 'rewards/xmlcount_reward_func': -0.8955000042915344, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.25, 'rewards/correctness_reward_func': 1.5, 'rewards/int_score_reward_func': 0.0, 'reward': 0.8544999957084656, 'reward_std': 1.7497987747192383, 'completion_length': 408.75, 'kl': 9.463889000471681e-06, 'epoch': 0.0}
  2%|‚ñè         | 5/250 [14:24<11:26:08, 168.04s/it]-------------------- Question:

            I have developed a model that can predict the drug likelibility of compound X.
            This model outputs two lists:
            1. The five most similar approved small molecules (with their properties and similarity scores).
            2. The five most similar non-approved small molecules (with their properties and similarity scores).

            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 206.28, 'LogP': 3.07, 'Molecular Refractivity': 61.03, 'TPSA': 37.3, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 1, 'Rotatable Bonds': 4, 'Chiral Centers': 1, 'Heavy Atoms': 15, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.98, 'Rdkit information': {'Molecular Weight': 206.28, 'LogP': 3.07, 'Molecular Refractivity': 61.03, 'TPSA': 37.30, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 1, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 15, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.96, 'Rdkit information': {'Molecular Weight': 165.19, 'LogP': 0.64, 'Molecular Refractivity': 45.76, 'TPSA': 63.32, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 12, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.95, 'Rdkit information': {'Molecular Weight': 244.26, 'LogP': 3.68, 'Molecular Refractivity': 67.89, 'TPSA': 37.30, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 1, 'Rotatable Bonds': 3, 'Chiral Centers': 0, 'Heavy Atoms': 18, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.94, 'Rdkit information': {'Molecular Weight': 171.24, 'LogP': 1.37, 'Molecular Refractivity': 46.83, 'TPSA': 63.32, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 3, 'Chiral Centers': 0, 'Heavy Atoms': 12, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}, 5: { 'similarity score': 0.94, 'Rdkit information': {'Molecular Weight': 250.34, 'LogP': 3.57, 'Molecular Refractivity': 72.06, 'TPSA': 46.53, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 6, 'Chiral Centers': 0, 'Heavy Atoms': 18, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['Aliphatic_long_chain']}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.93, 'Rdkit information': {'Molecular Weight': 172.27, 'LogP': 3.21, 'Molecular Refractivity': 50.25, 'TPSA': 37.30, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 1, 'Rotatable Bonds': 8, 'Chiral Centers': 0, 'Heavy Atoms': 12, 'Formal Charge': 0, 'Total Rings': 0, 'Structural Alerts': ['Aliphatic_long_chain']}}, 2: { 'similarity score': 0.93, 'Rdkit information': {'Molecular Weight': 158.13, 'LogP': -3.02, 'Molecular Refractivity': 35.15, 'TPSA': 40.13, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 2, 'Chiral Centers': 0, 'Heavy Atoms': 11, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 186.29, 'LogP': 3.46, 'Molecular Refractivity': 54.79, 'TPSA': 37.30, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 1, 'Rotatable Bonds': 8, 'Chiral Centers': 1, 'Heavy Atoms': 13, 'Formal Charge': 0, 'Total Rings': 0, 'Structural Alerts': ['Aliphatic_long_chain']}}, 4: { 'similarity score': 0.91, 'Rdkit information': {'Molecular Weight': 305.07, 'LogP': 1.11, 'Molecular Refractivity': 59.13, 'TPSA': 66.40, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 3, 'Chiral Centers': 0, 'Heavy Atoms': 14, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['iodine']}}, 5: { 'similarity score': 0.91, 'Rdkit information': {'Molecular Weight': 213.66, 'LogP': 1.86, 'Molecular Refractivity': 55.5, 'TPSA': 63.32, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 4, 'Chiral Centers': 1, 'Heavy Atoms': 14, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}}}
             
Answer:
approved 
Response:
<think>

First, I'll analyze the provided data to determine the likelihood of compound X receiving regulatory approval. The given data includes the five most similar approved and non-approved small molecules, along with their properties and similarity scores.

The approved molecules have high similarity scores (0.98, 0.96, 0.95, 0.94, and 0.94) with the compound X, which indicates that the compound X shares many structural and physico-chemical properties with known approved drugs. The properties of these approved drugs, such as molecular weight, LogP, molecular refractivity, TPSA, hydrogen bond donors and acceptors, rotatable bonds, chiral centers, and structural alerts, are very similar to compound X.

On the other hand, the non-approved molecules have lower similarity scores (0.93, 0.93, 0.92, 0.91, and 0.91) with the compound X, indicating that they share fewer structural and physico-chemical properties with compound X compared to the approved molecules.

Based on these observations, I would conclude that compound X has a higher likelihood of receiving regulatory approval due to its similarities with known approved small molecules.

Additionally, I'll consider the structural alerts of the approved molecules. All approved molecules do not contain any structural alerts whereas two non-approved molecules have alerts.

Therefore, based on the provided data, I would recommend that compound X has a good chance of receiving regulatory approval.

<label>
Approved
</label>
<score>
8/10
</score> 
Extracted:
Approved
  2%|‚ñè         | 6/250 [16:46<10:47:28, 159.21s/it]                                                   {'loss': 0.0, 'grad_norm': 0.24552175402641296, 'learning_rate': 1.0000000000000002e-06, 'rewards/xmlcount_reward_func': -0.7787500023841858, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.125, 'rewards/correctness_reward_func': 0.75, 'rewards/int_score_reward_func': 0.0, 'reward': 0.09624996781349182, 'reward_std': 2.160517692565918, 'completion_length': 386.0, 'kl': 9.713597137306351e-06, 'epoch': 0.0}
  2%|‚ñè         | 6/250 [16:46<10:47:28, 159.21s/it]-------------------- Question:

            I have developed a model that can predict the drug likelibility of compound X.
            This model outputs two lists:
            1. The five most similar approved small molecules (with their properties and similarity scores).
            2. The five most similar non-approved small molecules (with their properties and similarity scores).

            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 532.57, 'LogP': 4.46, 'Molecular Refractivity': 142.32, 'TPSA': 65.77, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 6, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 39, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['triple_bond']}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.82, 'Rdkit information': {'Molecular Weight': 434.53, 'LogP': 4.6, 'Molecular Refractivity': 113.67, 'TPSA': 26.71, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 5, 'Chiral Centers': 0, 'Heavy Atoms': 30, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': ['styrene_B(8)']}}, 2: { 'similarity score': 0.82, 'Rdkit information': {'Molecular Weight': 474.59, 'LogP': 1.61, 'Molecular Refractivity': 125.99, 'TPSA': 113.42, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 33, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.81, 'Rdkit information': {'Molecular Weight': 488.61, 'LogP': 2.07, 'Molecular Refractivity': 129.82, 'TPSA': 112.90, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 8, 'Chiral Centers': 0, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.81, 'Rdkit information': {'Molecular Weight': 439.39, 'LogP': 3.42, 'Molecular Refractivity': 105.47, 'TPSA': 107.15, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 6, 'Chiral Centers': 0, 'Heavy Atoms': 31, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['catechol_A(92)', 'catechol', 'nitro_group', 'Oxygen-nitrogen_single_bond']}}, 5: { 'similarity score': 0.81, 'Rdkit information': {'Molecular Weight': 506.61, 'LogP': 4.94, 'Molecular Refractivity': 140.71, 'TPSA': 75.00, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 37, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.86, 'Rdkit information': {'Molecular Weight': 431.46, 'LogP': 4.58, 'Molecular Refractivity': 112.87, 'TPSA': 47.36, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 6, 'Chiral Centers': 0, 'Heavy Atoms': 31, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': ['Aliphatic_long_chain']}}, 2: { 'similarity score': 0.84, 'Rdkit information': {'Molecular Weight': 503.57, 'LogP': 2.16, 'Molecular Refractivity': 138.65, 'TPSA': 125.00, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 9, 'Chiral Centers': 0, 'Heavy Atoms': 37, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['anil_di_alk_C(246)', 'Aliphatic_long_chain']}}, 3: { 'similarity score': 0.81, 'Rdkit information': {'Molecular Weight': 440.55, 'LogP': 4.89, 'Molecular Refractivity': 130.87, 'TPSA': 76.98, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 5, 'Chiral Centers': 0, 'Heavy Atoms': 33, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.8, 'Rdkit information': {'Molecular Weight': 456.49, 'LogP': 4.29, 'Molecular Refractivity': 112.77, 'TPSA': 79.58, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 31, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': ['nitro_group', 'Oxygen-nitrogen_single_bond']}}, 5: { 'similarity score': 0.8, 'Rdkit information': {'Molecular Weight': 460.59, 'LogP': 2.57, 'Molecular Refractivity': 133.79, 'TPSA': 91.21, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['anil_di_alk_A(478)']}}}}
             
Answer:
unapproved 
Response:
<think>
To determine the likelihood of compound X receiving regulatory approval, I will examine the similarity scores of approved and non-approved compounds.

The average similarity score with approved compounds is (0.82 + 0.82 + 0.81 + 0.81 + 0.81)/5 = 0.82. The highest similarity score is 0.82, achieved by two compounds. The average similarity score with non-approved compounds is (0.86 + 0.84 + 0.81 + 0.8 + 0.8)/5 = 0.82. The highest similarity score is 0.86, achieved by one compound.

Given that the highest similarity score for both approved and non-approved compounds is the same (0.82 and 0.86, respectively), we cannot simply compare the average or maximum similarity scores. However, the similarity score distribution suggests that compound X has higher similarity scores with non-approved compounds than approved ones. Furthermore, the highest similarity score with non-approved compounds is higher than the highest similarity score with approved compounds.

Although compound X seems to have higher similarity scores with non-approved compounds, the final decision depends on the consensus of both approved and non-approved compounds. Additionally, we need to consider other properties such as structural alerts.

Structural alerts are potential issues that could impact the compound's pharmaceutical properties. The structural alerts for compound X include a triple bond, which is not present in any of the similar approved drugs. However, one of the non-approved compounds (index 1 in the'most similar non-approved drugs') has an aliphatic long chain structural alert, which could be a concern.

Taking these factors into account, it seems that compound X has some promising features for an approved drug, but the presence of a triple bond as a structural alert may raise concerns.

The compound's similarity to approved drugs (0.82) is relatively high, but the similarity to non-approved compounds (0.86) is even higher. However, since the approved drugs have fewer structural issues, this could be a deciding factor.

The approved label is less likely because even though it has a moderate similarity score, many similar non-approved compounds with higher similarity scores exist.
</think>
<label>
Unapproved
</label>
<score>
7
</score> 
Extracted:
Unapproved
  3%|‚ñé         | 7/250 [18:55<10:04:31, 149.26s/it]                                                   {'loss': 0.0, 'grad_norm': 0.2934374213218689, 'learning_rate': 1.2000000000000002e-06, 'rewards/xmlcount_reward_func': -0.8255000114440918, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.125, 'rewards/correctness_reward_func': 0.75, 'rewards/int_score_reward_func': 0.0, 'reward': 0.04950001835823059, 'reward_std': 1.9348284006118774, 'completion_length': 359.75, 'kl': 1.0008697245211806e-05, 'epoch': 0.0}
  3%|‚ñé         | 7/250 [18:55<10:04:31, 149.26s/it]-------------------- Question:

            I have developed a model that can predict the drug likelibility of compound X.
            This model outputs two lists:
            1. The five most similar approved small molecules (with their properties and similarity scores).
            2. The five most similar non-approved small molecules (with their properties and similarity scores).

            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 473.58, 'LogP': 6.32, 'Molecular Refractivity': 146.59, 'TPSA': 78.94, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 36, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.83, 'Rdkit information': {'Molecular Weight': 558.65, 'LogP': 6.31, 'Molecular Refractivity': 157.25, 'TPSA': 111.79, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 12, 'Chiral Centers': 2, 'Heavy Atoms': 41, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.83, 'Rdkit information': {'Molecular Weight': 355.87, 'LogP': 5.18, 'Molecular Refractivity': 104.77, 'TPSA': 48.39, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 6, 'Chiral Centers': 0, 'Heavy Atoms': 25, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['mannich_A(296)', 'hydroquinone']}}, 3: { 'similarity score': 0.82, 'Rdkit information': {'Molecular Weight': 498.59, 'LogP': 6.51, 'Molecular Refractivity': 150.41, 'TPSA': 78.09, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 38, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.82, 'Rdkit information': {'Molecular Weight': 433.46, 'LogP': 0.3, 'Molecular Refractivity': 113.01, 'TPSA': 85.52, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 8, 'Chiral Centers': 0, 'Heavy Atoms': 31, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': 'None'}}, 5: { 'similarity score': 0.82, 'Rdkit information': {'Molecular Weight': 370.59, 'LogP': 5.89, 'Molecular Refractivity': 110.68, 'TPSA': 6.48, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 25, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': 'None'}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.84, 'Rdkit information': {'Molecular Weight': 472.59, 'LogP': 4.96, 'Molecular Refractivity': 136.81, 'TPSA': 68.74, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 35, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['isolated_alkene']}}, 2: { 'similarity score': 0.84, 'Rdkit information': {'Molecular Weight': 407.48, 'LogP': 4.24, 'Molecular Refractivity': 121.7, 'TPSA': 89.07, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 3, 'Chiral Centers': 0, 'Heavy Atoms': 31, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.82, 'Rdkit information': {'Molecular Weight': 591.56, 'LogP': 8.52, 'Molecular Refractivity': 158.31, 'TPSA': 97.75, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 6, 'Rotatable Bonds': 13, 'Chiral Centers': 1, 'Heavy Atoms': 39, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['Aliphatic_long_chain', 'Michael_acceptor_1']}}, 4: { 'similarity score': 0.82, 'Rdkit information': {'Molecular Weight': 444.54, 'LogP': 2.77, 'Molecular Refractivity': 125.98, 'TPSA': 96.25, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 6, 'Rotatable Bonds': 6, 'Chiral Centers': 4, 'Heavy Atoms': 33, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 5: { 'similarity score': 0.82, 'Rdkit information': {'Molecular Weight': 337.4, 'LogP': 4.44, 'Molecular Refractivity': 94.68, 'TPSA': 60.17, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 3, 'Chiral Centers': 0, 'Heavy Atoms': 24, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': 'None'}}}}
             
Answer:
unapproved 
Response:
<think>
To assess the likelihood of Compound X receiving regulatory approval, we need to analyze its similarity to approved and non-approved drugs. 

First, let's look at the similarities between Compound X and approved drugs. The highest similarity score is 0.83, which is quite high. Among the most similar approved drugs, we see that their Molecular Weights, Logs P, and Molecular Refractivities are close to those of Compound X. Specifically, the molecular structures of these approved drugs have similar numbers of hydrogen bond donors and acceptors.

Now, let's consider the similarities between Compound X and non-approved drugs. The highest similarity score is also 0.84, which is slightly higher than the scores for the approved drugs. The most similar non-approved drugs have similar molecular weights, Log P values, and molecular refractivities as well. However, these non-approved drugs have more warning signs such as the aliphatic long chain and Michael acceptor in some of their structures.

Taking these observations into account, it seems that Compound X bears some resemblance to both approved and non-approved substances. Nevertheless, we can't completely disregard the fact that its structural alerts suggest potential issues.

Therefore, the weight of evidence, despite some red flags, suggests that Compound X might be put through further evaluation as a potential drug candidate.

</think>
<label>
Approved
</label>
<score>
7/10
</score> 
Extracted:
Approved
  3%|‚ñé         | 8/250 [21:43<10:26:19, 155.29s/it]                                                   {'loss': 0.0, 'grad_norm': 0.2674553096294403, 'learning_rate': 1.4000000000000001e-06, 'rewards/xmlcount_reward_func': -1.4505000114440918, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.0, 'rewards/correctness_reward_func': 0.0, 'rewards/int_score_reward_func': 0.0, 'reward': -1.4505000114440918, 'reward_std': 0.8023750185966492, 'completion_length': 442.25, 'kl': 1.1067396371799987e-05, 'epoch': 0.0}
  3%|‚ñé         | 8/250 [21:43<10:26:19, 155.29s/it]slurmstepd: error: *** JOB 110399 ON en-7-1 CANCELLED AT 2025-04-11T02:16:51 ***
#################################################
Panthera Cluster
Job 110399 for user 'u111169'
Finished at: Fri Apr 11 02:16:55 +0330 2025
Job details file : ~/JobSummary/110399.out
================================================
